Management strategies in patients affected by chronic total occlusions: results from the Italian Registry of Chronic Total Occlusions

SD Tomasello, M Boukhris, S Giubilato… - European heart …, 2015 - academic.oup.com
Background Through contemporary literature, the optimal strategy to manage coronary chronic
total occlusions (CTOs) remains under debate. Objectives The aim of the Italian Registry …

Expansion of CD4+CD28null T-lymphocytes in diabetic patients: exploring new pathogenetic mechanisms of increased cardiovascular risk in diabetes mellitus

S Giubilato, G Liuzzo, S Brugaletta… - European heart …, 2011 - academic.oup.com
Aims Diabetes mellitus (DM) is associated with high incidence of first and recurrent
cardiovascular events, especially acute coronary syndromes (ACSs); however, the mechanisms …

Severity of coronary atherosclerosis in patients with a first acute coronary event: a diabetes paradox

G Niccoli, S Giubilato, L Di Vito, A Leo… - European heart …, 2013 - academic.oup.com
Aims We aimed to compare coronary artery disease (CAD) at the time of a first acute coronary
syndrome (ACS) in type II diabetic and non-diabetic patients by coronary angiography and …

Update on management of cardiovascular diseases in women

…, I Parrini, SA Di Fusco, S Giubilato… - Journal of clinical …, 2022 - mdpi.com
Cardiovascular diseases (CVD) have a lower prevalence in women than men; although, a
higher mortality rate and a poorer prognosis are more common in women. However, there is a …

Management of residual risk in chronic coronary syndromes. Clinical pathways for a quality-based secondary prevention

S Giubilato, F Lucà, MG Abrignani, L Gatto… - Journal of Clinical …, 2023 - mdpi.com
Chronic coronary syndrome (CCS), which encompasses a broad spectrum of clinical
presentations of coronary artery disease (CAD), is the leading cause of morbidity and mortality …

Plasma levels of thromboxane A2 on admission are associated with no-reflow after primary percutaneous coronary intervention

G Niccoli, S Giubilato, E Russo, C Spaziani… - European Heart …, 2008 - academic.oup.com
Aims Thromboxane A2 (TXA2) is a key mediator of platelet activation and aggregation, and
an important mediator of platelet-induced coronary artery constriction. We sought to …

COX-1 sensitivity and thromboxane A2 production in type 1 and type 2 diabetic patients under chronic aspirin treatment

…, LM Biasucci, S Riondino, S Giubilato… - European heart …, 2009 - academic.oup.com
Aims Although aspirin treatment is useful in reducing ischaemic events in diabetic patients,
recent studies suggest that it is less effective when compared with non-diabetics (ND). We …

Adaptive immunity, inflammation, and cardiovascular complications in type 1 and type 2 diabetes mellitus

…, F Trotta, AF Giglio, S Giubilato… - Journal of diabetes …, 2013 - Wiley Online Library
Diabetes mellitus (DM) is a pandemics that affects more than 170 million people worldwide,
associated with increased mortality and morbidity due to coronary artery disease (CAD). In …

Long-term clinical and angiographic outcomes of the mini-STAR technique as a bailout strategy for percutaneous coronary intervention of chronic total occlusion

…, SD Tomasello, F Marzà, S Azzarelli, S Giubilato… - Canadian Journal of …, 2014 - Elsevier
Background A promising variant of the subintimal tracking and re-entry (STAR) technique,
called “mini-STAR,” has been recently described as a successful rescue technique after …

Combined atherogenic effects of celiac disease and type 1 diabetes mellitus

D Pitocco, S Giubilato, F Martini, F Zaccardi, V Pazzano… - Atherosclerosis, 2011 - Elsevier
OBJECTIVE: Previous studies have shown a high cardiovascular risk in patients with autoimmune
diseases, such as type 1 diabetes mellitus (T1DM). Conversely, few data are available …